Introduction Osteoarthritis (OA) exhibits substantial heterogeneity in synovial immune profiles, which may underlie variable analgesic responses to standard biological and neuromodulatory treatments. Remodeling the immune microenvironment while targeting nociceptive pathways may improve therapeutic consistency. Methods...
Peng Liu, Jing-Wei Zhu, Yang Yang et al.· Frontiers in Pharmacology· 0 citations
The findings decipher a novel H3K18la/IGF2BP2/MARCKSL1 signaling cascade that integrates metabolic reprogramming with m6A epitranscriptomics in ALI, highlighting IGF2BP2 as a promising target for preventive intervention in airway epithelial inflammation.
Yangdi Peng, Jun-Yao Zhang, Yang Yang et al.· Molecular Immunology· 0 citations
Missed nursing care (MNC) in intensive care units (ICUs) is associated with adverse patient outcomes, yet multicentre evidence from mainland China remains limited.
Su-Jun Xiao, Rong Jiang, Qin Xiong et al.· Nursing Critical Care· 0 citations
OPD functions as a novel molecular degrader of KIF11, exerting its anti-LUAD effects by promoting KIF11 ubiquitination and subsequent proteasomal degradation.